Trials / Completed
CompletedNCT01359787
Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)
Double-blind, Randomized, Vehicle-controlled, Multicenter, Multinational, Parallel-group Study of the Efficacy and Safety of Mapracorat Ointment in Three Concentrations Over Max. 4 Weeks in Subjects With Atopic Dermatitis (AD)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 197 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of three concentrations of a development drug compared to ointment base (vehicle) in subjects with Atopic Dermatitis (AD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mapracorat | Daily topical application |
| DRUG | Vehicle without active | Daily topical application |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2011-05-25
- Last updated
- 2015-01-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01359787. Inclusion in this directory is not an endorsement.